Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|June 13, 2017

Waters Collaborates with IonSense

The companies are collaborating to interface the Waters Acquity QDa Mass Detector with the IonSense DART ionization source.

On Jun 1, 2017, Waters announced that it will be collaborating with IonSense to interface the Waters Acquity QDa Mass Detector with the IonSense DART ionization source. The combination of the two products will enable the rapid generation of mass data directly from liquid or solid samples with little or no sample preparation. According to the companies, this tool will be useful for medicinal chemists monitoring reactions, forensic investigators, and product quality groups, among others.

“Since its introduction in 2013, the QDa detector has brought the benefits of high-quality mass spectral information to a broad spectrum of applications in a number of industries,” said Gary Harland, senior director, Mass Spectrometry Product Management, Waters Corporation in a statement. “Our collaborative engagement with IonSense promises to make mass spectral data accessible to even more customers and markets.” 

Source: Waters 


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.